PVRIG and cancer: Collectively, our study suggests that targeting PVRIG with therapeutic mAb can be a promising way to treat cancer via reversing exhaustion of both NK cells and CTLs, from which we highlight the importance of NK cells in PVRIG blockade and suggest that more attention needs to be paid on NK cells in PVRIG-targeted treatments.